Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 16/20 | 0.51 |
| ▸ | CA9 | Q16790 | 14/20 | 0.51 |
| ▸ | CA1 | P00915 | 14/20 | 0.51 |
| ▸ | CA12 | O43570 | 13/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8250269 | 0.78 | SLC18A3 (0.43) | CA2CA9CA1CA12 | |
| SCHEMBL28601412 | 0.77 | CA12 (0.39) | PTGS2CA2CA9CA1CA12 | |
| SCHEMBL28598700 | 0.77 | GLA (0.41) | PTGS2CA2CA9CA1CA12 | |
| SCHEMBL8505690 | 0.76 | PTGES2 (0.37) | PTGS2CA2CA9CA1CA12 | |
| SCHEMBL12504926 | 0.75 | GLA (0.39) | PTGS2CA2CA9CA1CA12 | |
| SCHEMBL28602234 | 0.74 | ALDH1A1 (0.46) | CA2CA9CA1CA12 | |
| SCHEMBL28601637 | 0.74 | SMN1; SMN2 (0.43) | — | |
| SCHEMBL28606349 | 0.74 | KCNH2 (0.44) | — | |
| SCHEMBL7209882 | 0.73 | PTGS2 (0.78) | PTGS2CA2CA9CA1CA12 | |
| SCHEMBL28609103 | 0.71 | PGR (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0946507-B1 | SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2003-09-24 | — | — | EP | claimed |
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | disclosed |